Status:
COMPLETED
Reported Time Between Onset and Diagnosis of Alzheimer's Disease: Correlation With Objective Parameters
Lead Sponsor:
Murielle Surquin
Conditions:
Alzheimer Disease
Eligibility:
All Genders
Brief Summary
The early diagnosis of Alzheimer's disease is essential to enable patients to have access to the available treatments. However, there is a delay between the diagnosis and the onset of symptoms, which ...
Eligibility Criteria
Inclusion
- Alzheimer Disease patients admitted in the 'Memory Clinic' of the CHU Brugmann Hospital between 01-01-2010 and 31-01-2013. Diagnose according to the Dubois criteria
Exclusion
- None
Key Trial Info
Start Date :
May 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2017
Estimated Enrollment :
129 Patients enrolled
Trial Details
Trial ID
NCT03408041
Start Date
May 1 2016
End Date
October 1 2017
Last Update
January 23 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Brugmann
Brussels, Belgium